المؤلفون: García Alfonso, María Pilar, Vera García, Ruth, Aranda, Enrique, Élez, Elena, Rivera, Fernando

مصطلحات موضوعية: 616-006.04, Delphi, Quality of life (QoL), Rechallenge, Regorafenib, Therapeutic sequence, Trifluridine/tipiracil (FTD/TPI), Oncología, 3207.13 Oncología

وصف الملف: application/pdf

العلاقة: https://hdl.handle.net/20.500.14352/103242Test; García-Alfonso P, Vera R, Aranda E, Élez E, Rivera F. Delphi consensus for the third-line treatment of metastatic colorectal cancer. Clin Transl Oncol. 2024 Feb 27. doi:10.1007/s12094-023-03369-1; https://link.springer.com/article/10.1007/s12094-023-03369-1Test

الإتاحة: https://doi.org/20.500.14352/103242Test
https://doi.org/10.1007/s12094-023-03369-1Test
https://hdl.handle.net/20.500.14352/103242Test

المؤلفون: Lüftner, Diana, Fasching, Peter A., Haidinger, Renate, Harbeck, Nadia, Jackisch, Christian, Müller, Volkmar, Schumacher-Wulf, Eva, Thomssen, Christoph, Untch, Michael, Würstlein, Rachel

مصطلحات موضوعية: Advanced breast cancer, Systemic therapy, Therapeutic sequence, Oligometastasis disease, Brain metastases, Supportive care, ddc:610

وصف الملف: application/pdf

العلاقة: https://refubium.fu-berlin.de/handle/fub188/39824Test; http://dx.doi.org/10.17169/refubium-39545Test

الإتاحة: https://doi.org/10.17169/refubium-39545Test
https://doi.org/10.1159/000522068Test
https://refubium.fu-berlin.de/handle/fub188/39824Test

المؤلفون: Albertelli M., Dotto A., Di Dato C., Malandrino P., Modica R., Versari A., Colao A., Ferone D., Faggiano A.

المساهمون: Albertelli, M., Dotto, A., Di Dato, C., Malandrino, P., Modica, R., Versari, A., Colao, A., Ferone, D., Faggiano, A.

مصطلحات موضوعية: neuroendocrine tumor, peptide receptor radionuclide therapy, predictor, response, therapeutic sequence

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/32978685; info:eu-repo/semantics/altIdentifier/wos/WOS:000572693000001; issue:Sep 25; firstpage:1; lastpage:17; numberofpages:17; journal:REVIEWS IN ENDOCRINE & METABOLIC DISORDERS; http://hdl.handle.net/11573/1465534Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85091612367

الإتاحة: https://doi.org/10.1007/s11154-020-09581-6Test
http://hdl.handle.net/11573/1465534Test

المؤلفون: Diana Lüftner, Peter A. Fasching, Renate Haidinger, Nadia Harbeck, Christian Jackisch, Volkmar Müller, Eva Schumacher-Wulf, Christoph Thomssen, Michael Untch, Rachel Würstlein

المصدر: Breast Care (Basel)

مصطلحات موضوعية: Oncology, Systemic therapy, Therapeutic sequence, Conference Report, Surgery, Advanced breast cancer, Brain metastases, Oligometastasis disease, 600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit, Supportive care

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75ffb57312405f315ab7f185619bbaa5Test
https://doi.org/10.1159/000522068Test

المؤلفون: Francesco Grillone, Giuseppe Procopio, Andrea Sbrana, Delia De Lisi, Daniele Santini, Sandro Pignata, Francesca Vignani, Sebastiano Buti, Emanuele Naglieri, Laura Attademo, Marco Maruzzo, Marco Stellato, Rocco De Vivo, Melissa Bersanelli, Davide Bimbatti, Francesco Pantano, Elena Verzoni, Mariella Sorarù, Ugo De Giorgi, Giuseppe Fornarini, Claudia Mucciarini, Chiara Casadei, Giuseppe Di Lorenzo, Enrico Mini

المصدر: American journal of clinical oncology. 44(3)

مصطلحات موضوعية: Male, Cancer Research, medicine.medical_specialty, Cabozantinib, Pyridines, Programmed Cell Death 1 Receptor, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Renal cell carcinoma, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Anilides, 030212 general & internal medicine, Progression-free survival, Everolimus, Adverse effect, Carcinoma, Renal Cell, Immune Checkpoint Inhibitors, Aged, Retrospective Studies, business.industry, Hazard ratio, Retrospective cohort study, Middle Aged, medicine.disease, cabozantinib, immune-oncology, immunotherapy, renal cell carcinoma, therapeutic sequence, Carcinoma, Renal Cell, Disease Progression, Female, Italy, Kidney Neoplasms, Nivolumab, Treatment Outcome, Confidence interval, Oncology, chemistry, 030220 oncology & carcinogenesis, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a347a85f9d38514807dad0da00368341Test
https://pubmed.ncbi.nlm.nih.gov/33617179Test

المؤلفون: Santini D, Stellato M, De Giorgi U, Pantano F, De Lisi D, Casadei C, Maruzzo M, Bimbatti D, Naglieri E, Buti S, Bersanelli M, De Vivo R, Di Lorenzo G, Sbrana A, Verzoni E, Soraru' M, Fornarini G, Mucciarini C, Grillone F, Mini E, Vignani F, Attademo L, Pignata S, Procopio G

المساهمون: Santini, D, Stellato, M, De Giorgi, U, Pantano, F, De Lisi, D, Casadei, C, Maruzzo, M, Bimbatti, D, Naglieri, E, Buti, S, Bersanelli, M, De Vivo, R, Di Lorenzo, G, Sbrana, A, Verzoni, E, Soraru', M, Fornarini, G, Mucciarini, C, Grillone, F, Mini, E, Vignani, F, Attademo, L, Pignata, S, Procopio, G

مصطلحات موضوعية: cabozantinib, immune-oncology, immunotherapy, renal cell carcinoma, therapeutic sequence, Aged, Anilide, Antineoplastic Combined Chemotherapy Protocol, Carcinoma, Renal Cell, Disease Progression, Everolimu, Female, Human, Immune Checkpoint Inhibitor, Italy, Kidney Neoplasm, Male, Middle Aged, Nivolumab, Programmed Cell Death 1 Receptor, Pyridine, Retrospective Studie, Treatment Outcome

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/33617179; info:eu-repo/semantics/altIdentifier/wos/WOS:000622345800006; volume:44; issue:3; firstpage:121; lastpage:125; numberofpages:5; journal:AMERICAN JOURNAL OF CLINICAL ONCOLOGY: CANCER CLINICAL TRIALS; https://hdl.handle.net/11573/1641932Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85101735961

الإتاحة: https://doi.org/10.1097/COC.0000000000000791Test
https://hdl.handle.net/11573/1641932Test

المؤلفون: Albertelli M., Dotto A., Di Dato C., Malandrino P., Modica R., Versari A., Colao A., Ferone D., Faggiano A.

المساهمون: Albertelli, M., Dotto, A., Di Dato, C., Malandrino, P., Modica, R., Versari, A., Colao, A., Ferone, D., Faggiano, A.

مصطلحات موضوعية: Neuroendocrine tumor, Peptide receptor radionuclide therapy, Predictor, Response, Therapeutic sequence

العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000572693000001; volume:22; issue:3; firstpage:563; lastpage:579; numberofpages:17; journal:REVIEWS IN ENDOCRINE & METABOLIC DISORDERS; https://hdl.handle.net/11588/905771Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85091612367

الإتاحة: https://doi.org/10.1007/s11154-020-09581-6Test
https://hdl.handle.net/11588/905771Test

المؤلفون: Annibale Versari, Pasqualino Malandrino, Roberta Modica, A. Colao, Diego Ferone, Antongiulio Faggiano, Andrea Dotto, Nike, C. Di Dato, Manuela Albertelli

المساهمون: Albertelli, M., Dotto, A., Di Dato, C., Malandrino, P., Modica, R., Versari, A., Colao, A., Ferone, D., Faggiano, A.

المصدر: Reviews in Endocrine & Metabolic Disorders

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Liver tumor, Peptide receptor, Therapeutic sequence, Endocrinology, Diabetes and Metabolism, Therapeutic algorithm, Neuroendocrine tumors, Octreotide, Article, Peptide receptor radionuclide therapy, 030218 nuclear medicine & medical imaging, 03 medical and health sciences, 0302 clinical medicine, Endocrinology, Neuroendocrine tumor, Internal medicine, Positron Emission Tomography Computed Tomography, medicine, Organometallic Compounds, Humans, Grading (tumors), business.industry, Response, medicine.disease, Prognosis, Primary tumor, 030220 oncology & carcinogenesis, Predictor, Radionuclide therapy, Ki67 index, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3b2047f4649a52a025f72e62b087f39Test
http://hdl.handle.net/11567/1026329Test

المؤلفون: Richter Igor, Dvořák Josef

مصطلحات موضوعية: prostate cancer, metastases, chemotherapy, hormonal treatment, therapeutic sequence

العلاقة: Prague Onco Journal; https://dspace.tul.cz/handle/15240/158702Test

الإتاحة: https://dspace.tul.cz/handle/15240/158702Test